Six deaths and 224 new cases of COVID-19 were announced Tuesday, as well as 238 recoveries.

Of those who tested positive for COVID-19 and died, one was in their 40's from the southeast, two were in their 60's from the southwest and Regina, and three were in the 80-plus age group from the southeast (2) and Regina (1).

Of the new cases, 6 are located in the south-central zone, 70 are in Saskatoon, 43 in the northwest, 30 in Regina, 21 in the central-east, 17 in the north-central zone, 11 in the southeast, eight in the far northwest, five in the northeast, four in the southwest, and two in the central-west. Seven new cases are pending resident information.

2,518 cases are considered active with 89 of those located in the sub-region 'south-central 2' which is made up of Moose Jaw and the surrounding area.

186 people are in hospital with 144 receiving inpatient care, and 42 are in intensive care.

Vaccine Eligibility 

The government also announced that starting Wednesday, all individuals aged 42 and up will be eligible to book their vaccine.

Effective Friday, everyone 40 and up will be eligible.

Additional priority workers also eligible include police, firefighters, volunteer firefighters, public health inspectors, teachers and educational staff working with students, and all previously identified frontline health care workers.

Vaccines Reported

An additional 5,045 doses of the COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 408,429.

The 5,045 doses of COVID-19 vaccine reported today were administered to residents living in the following zones: Far North West, 15; Far North Central, 1; Far North East, 18; North West, 370; North Central, 305; North East, 146; Saskatoon, 3,103; Central West, 202; Central East, 119; Regina, 330; South West, 39; South Central, 38; and South East, 75. There were 284 doses administered with zone of residence pending.

Fifty-eight per cent of Saskatchewan residents over age 40 have received their first dose. Thirty-nine per cent of those 18+ have received their first dose.